Mr. Zindrick has served as our Chairman since July 2021, and as a member of our Board of Directors and President and CEO since 2014.
Mr. Zindrick brings over 30 years of executive experience in the life sciences and biotechnology. Since 2018, he has served on the Board, and currently serves as Executive Chair, of Aeromics, Inc, a clinical-stage pharmaceutical company developing products for the treatment of ischemic stroke.
He previously served on the board of directors of Amitech Therapeutic Solutions, Inc. from 2011 to February 2021 and DNX Biopharmaceuticals, Inc. from November 2014 to March 2020. From 1993 to 2009, Mr. Zindrick was at Amgen, where he held positions of increasing responsibility, including Vice President Associate General Counsel and Chief Compliance Officer. Prior to joining Amgen, he was an attorney at The Dow Chemical Company.
Mr. Zindrick received his J.D. from the University of Illinois College of Law and a BA in Biology from North Central College in Naperville, Illinois.
What is Thomas Zindrick's net worth?
The estimated net worth of Thomas Zindrick is at least $3.63 million as of August 4th, 2026. Mr. Zindrick owns 1,260,890 shares of Genelux stock worth more than $3,631,363 as of August 27th. This net worth approximation does not reflect any other investments that Mr. Zindrick may own. Learn More about Thomas Zindrick's net worth.
How do I contact Thomas Zindrick?
Has Thomas Zindrick been buying or selling shares of Genelux?
Over the course of the past ninety days, Thomas Zindrick has sold $8,917.85 in shares of Genelux stock. Most recently, Thomas Zindrick sold 3,023 shares of the business's stock in a transaction on Tuesday, August 4th. The shares were sold at an average price of $2.95, for a transaction totalling $8,917.85. Following the completion of the sale, the chief executive officer now directly owns 1,260,890 shares of the company's stock, valued at $3,719,625.50. Learn More on Thomas Zindrick's trading history.
Who are Genelux's active insiders?
Are insiders buying or selling shares of Genelux?
In the last year, insiders at the sold shares 15 times. They sold a total of 56,111 shares worth more than $199,950.70. The most recent insider tranaction occured on August, 4th when insider Yong Yu sold 653 shares worth more than $1,919.82. Insiders at Genelux own 7.5% of the company.
Learn More about insider trades at Genelux. Information on this page was last updated on 8/4/2026.
